GreenBone achieves aim of recruiting 15 patients into the GreenBRIC study in the treatment of iliac crest reconstruction.

GreenBone Ortho today announces that it has achieved its aim of recruiting 15 patients into the GreenBRIC study. GreenBRIC study is a prospective, open label, single-arm, First-in-Human clinical investigation, in male and female patients, aged between 18 and 70 years, undergoing surgery to correct bone defects using GreenBone Implant, specifically for iliac crest reconstruction.

The primary objective of this study is to evaluate the safety of GreenBone Implant and the secondary objective is to evaluate its performance. The surgical procedure will be performed as per standard of care at the investigational site.

To read the full press release click here



You are entering an area containing information intended for healthcare professionals. If you are a healthcare professional, click here to continue.




GreenBoneTM Bone Substitute received CE mark approval